Rand Paul pandemic research bill breezes through Senate homeland security committee

A Senate panel voted Wednesday to approve a biomedical security bill sponsored by Sen. Rand Paul (R-KY) that would create an executive branch board to conduct oversight of life science research with pandemic-causing abilities, a measure inspired by the research conducted in Wuhan, China, prior to the COVID-19 pandemic.

The Risky Research Review Act advanced from the Senate Homeland Security and Government Affairs Committee in an 11-2 vote, with two Democrats voting against. The panel also approved the bill last Congress in an 8-1 vote, but it never received a vote on the Senate floor.